• Home
  •  / PURE Bioscience

PURE Bioscience

OverviewSuggest Edit

PURE Bioscience is a company developing and commercializing antimicrobial products. It develops a technology platform based on stabilized ionic silver and products containing silver dihydrogen citrate (SDC). In addition, the Company manufactures and distributes SDC-based disinfecting and sanitizing products. It produces and supplies SDC-based formulations for the production of personal care products.

TypePublic
Founded1992
HQRancho Cucamonga, CA, USMap
Websitepurebio.com

Recent NewsAll News

Latest Updates

Employees (est.) (Oct 2019)10(+12%)
Revenue (FY, 2020)$6.9 M(+263%)
Share Price (Jan 2021)$0.8
Cybersecurity ratingAMore

Key People/Management at PURE Bioscience

Tom Y. Lee

Tom Y. Lee

Chief Executive Officer, President, Director
Mark Elliott

Mark Elliott

Vice President, Finance
Tom Myers

Tom Myers

Chief Operating Officer
Dolana Blount

Dolana Blount

Vice President, Technology Development and Regulatory Affairs
Bridget C. Tinsley-Cormier

Bridget C. Tinsley-Cormier

Vice President, Market Development
Jason Kawata

Jason Kawata

Vice President of Technology, Food Division
Show more

PURE Bioscience Office Locations

PURE Bioscience has offices in Rancho Cucamonga and El Cajon
Rancho Cucamonga, CA, US (HQ)
9669 Hermosa Ave
El Cajon, CA, US
1725 Gillespie Way
El Cajon, CA, US
771 Jamacha Road #512
Show all (3)

PURE Bioscience Financials and Metrics

PURE Bioscience Revenue

Embed Graph
View revenue for all periods
PURE Bioscience's revenue was reported to be $6.92 m in FY, 2020
USD

Revenue (Q1, 2021)

1.6m

Gross profit (Q1, 2021)

950.0k

Gross profit margin (Q1, 2021), %

59.7%

Net income (Q1, 2021)

(180.0k)

EBIT (Q1, 2021)

(179.0k)

Market capitalization (15-Jan-2021)

72.0m

Closing stock price (15-Jan-2021)

0.8

Cash (31-Oct-2020)

3.5m
PURE Bioscience's current market capitalization is $72 m.
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019FY, 2020

Revenue

820.0k550.0k729.0k1.3m1.8m1.8m1.9m6.9m

Cost of goods sold

565.0k344.0k285.0k441.0k760.0k763.0k728.0k2.9m

Gross profit

255.0k206.0k444.0k848.0k1.1m1.0m1.2m4.0m

Gross profit Margin, %

31%37%61%66%58%57%62%58%
Quarterly
USDQ1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021

Revenue

257.0k221.0k207.0k110.0k263.0k258.0k115.0k41.0k261.0k117.0k273.0k109.0k186.0k176.0k403.0k531.0k447.0k338.0k464.0k411.0k390.0k590.0k394.0k312.0k398.0k349.0k2.2m1.6m

Cost of goods sold

129.0k40.0k37.0k31.0k57.0k67.0k36.0k20.0k89.0k45.0k111.0k65.0k54.0k48.0k116.0k265.0k134.0k132.0k146.0k161.0k166.0k203.0k160.0k117.0k156.0k142.0k972.0k641.0k

Gross profit

128.0k181.0k170.0k79.0k206.0k191.0k79.0k21.0k172.0k72.0k162.0k44.0k132.0k128.0k287.0k266.0k313.0k206.0k318.0k250.0k224.0k387.0k234.0k195.0k242.0k207.0k1.2m950.0k

Gross profit Margin, %

50%82%82%72%78%74%69%51%66%62%59%40%71%73%71%50%70%61%69%61%57%66%59%63%61%59%56%60%
show all
Annual
USDFY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019FY, 2020

Cash

877.0k32.0k86.0k1.3m5.2m1.6m851.0k398.0k3.8m

Accounts Receivable

373.0k18.0k47.0k189.0k263.0k297.0k275.0k373.0k1.1m

Prepaid Expenses

347.0k71.0k96.0k187.0k174.0k58.0k18.0k16.0k

Inventories

654.0k365.0k249.0k207.0k350.0k273.0k197.0k177.0k547.0k
Quarterly
USDQ1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021

Cash

992.0k626.0k289.0k2.5m920.0k410.0k1.1m236.0k416.0k5.3m3.9m2.5m6.1m6.7m5.4m4.1m3.9m2.7m3.2m2.1m1.0m776.0k335.0k340.0k904.0k246.0k2.0m3.5m

Accounts Receivable

119.0k16.0k193.0k64.0k95.0k29.0k31.0k9.0k34.0k47.0k40.0k86.0k93.0k106.0k68.0k146.0k142.0k185.0k143.0k146.0k192.0k353.0k129.0k134.0k220.0k156.0k1.6m560.0k

Prepaid Expenses

189.0k482.0k432.0k80.0k85.0k110.0k231.0k221.0k194.0k154.0k75.0k33.0k150.0k88.0k312.0k331.0k189.0k154.0k175.0k104.0k52.0k71.0k49.0k28.0k30.0k15.0k10.0k46.0k

Inventories

850.0k889.0k901.0k864.0k836.0k781.0k430.0k429.0k387.0k231.0k186.0k207.0k219.0k237.0k320.0k348.0k340.0k348.0k274.0k267.0k275.0k209.0k205.0k195.0k162.0k141.0k282.0k733.0k
show all
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019FY, 2020

Net Income

(7.7m)(11.0m)(7.6m)(14.4m)(6.3m)(7.4m)(6.6m)4.0k

Depreciation and Amortization

311.0k248.0k206.0k219.0k276.0k285.0k241.0k192.0k

Inventories

149.0k(12.0k)42.0k(143.0k)27.0k37.0k20.0k(370.0k)

Accounts Payable

962.0k(96.0k)(955.0k)(131.0k)(59.0k)103.0k(40.0k)774.0k
Quarterly
USDQ1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021

Net Income

(2.4m)(4.6m)(1.8m)(2.2m)(4.0m)(5.5m)(3.8m)(6.3m)(8.4m)(1.9m)(3.7m)(5.8m)(2.8m)(13.7m)(13.7m)(1.7m)(2.7m)(4.4m)(2.3m)(4.4m)(6.1m)(2.6m)(3.9m)(5.7m)(1.1m)(1.8m)(1.3m)(180.0k)

Depreciation and Amortization

117.0k216.0k73.0k158.0k236.0k73.0k140.0k196.0k51.0k103.0k154.0k51.0k103.0k154.0k65.0k134.0k204.0k71.0k142.0k213.0k71.0k143.0k191.0k52.0k100.0k145.0k45.0k

Inventories

11.0k(28.0k)(3.0k)25.0k80.0k(65.0k)(64.0k)(22.0k)18.0k63.0k42.0k(12.0k)(30.0k)(113.0k)2.0k10.0k2.0k(1.0k)(20.0k)17.0k(12.0k)(8.0k)2.0k15.0k36.0k(105.0k)(186.0k)

Accounts Payable

438.0k935.0k209.0k234.0k487.0k42.0k(275.0k)(588.0k)(955.0k)(1.0m)(1.1m)(250.0k)(33.0k)(125.0k)147.0k(36.0k)58.0k(38.0k)7.0k(52.0k)(206.0k)(128.0k)(255.0k)139.0k(46.0k)753.0k(606.0k)
show all
USDQ1, 2012

Financial Leverage

1.5 x
Show all financial metrics

PURE Bioscience Cybersecurity Score

Cybersecurity ratingPremium dataset

A

92/100

Learn more about our premium products
SecurityScorecard logo

PURE Bioscience Online and Social Media Presence

PURE Bioscience's Trends

Embed Graph

PURE Bioscience News and Updates

June 13, 2018

PURE Bioscience, Inc. (PURE) CEO Hank Lambert on Q3 2018 Results - Earnings Call Transcript

 PURE Bioscience Frequently Asked Questions

  • When was PURE Bioscience founded?

    PURE Bioscience was founded in 1992.

  • Who are PURE Bioscience key executives?

    PURE Bioscience's key executives are Tom Y. Lee, Mark Elliott and Tom Myers.

  • How many employees does PURE Bioscience have?

    PURE Bioscience has 10 employees.

  • What is PURE Bioscience revenue?

    Latest PURE Bioscience annual revenue is $6.9 m.

  • What is PURE Bioscience revenue per employee?

    Latest PURE Bioscience revenue per employee is $691.7 k.

  • Who are PURE Bioscience competitors?

    Competitors of PURE Bioscience include Biosan Laboratories, 2XL and Peptilogics.

  • Where is PURE Bioscience headquarters?

    PURE Bioscience headquarters is located at 9669 Hermosa Ave, Rancho Cucamonga.

  • Where are PURE Bioscience offices?

    PURE Bioscience has offices in Rancho Cucamonga and El Cajon.

  • How many offices does PURE Bioscience have?

    PURE Bioscience has 3 offices.